CHINARES PHARMA has completed the issuance of 1.1 billion yuan corporate bonds
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, CHINARES PHARMA announced that the first phase of its 2025 corporate bonds, with a total principal amount of RMB 1.1 billion, has been issued. The term is three years, with a coupon annual interest rate of 1.82%. The net proceeds will be used for productive expenditures, including repaying corporate debts, supplementing working capital, project development and operational expenditures, investments related to technological innovation, and other uses that comply with applicable laws and regulations
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments